This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Lofarma S.p.a.. Active years: 2014-2020.
Company Filing History:
Years Active: 2014-2020
Title: Dario Zanoni: Innovator in Allergy Treatment
Introduction
Dario Zanoni is a notable inventor based in Milan, Italy. He has made significant contributions to the field of allergy treatment through his innovative patents. With a total of 2 patents, his work focuses on developing safer and more effective methods for immunotherapy.
Latest Patents
Zanoni's latest patents include groundbreaking inventions related to allergenic materials. One of his patents describes a method for creating allergoids derived from allergens, which have reduced allergenicity while preserving immunogenicity. This method involves functionalizing primary amine groups of lysine and arginine residues in native allergenic materials. The raw allergenic materials used in this process include extracts from dust mites, ovalbumin, and Lipid Transfer Protein (LTP).
Another significant patent involves the preparation of purified allergens and allergoids from bee venom. This invention aims to provide a safer immunotherapy option for individuals with specific allergies. The preparation is characterized by being essentially free of mellitin, a component known to cause adverse reactions. The resulting allergoid is designed to have reduced IgE-binding activity, making it a promising candidate for effective immunotherapy.
Career Highlights
Dario Zanoni is associated with Lofarma S.p.a., a company dedicated to developing innovative solutions in the field of allergy treatment. His work has been instrumental in advancing the understanding and management of allergic reactions.
Collaborations
Zanoni collaborates with esteemed colleagues such as Giovanni Mistrello and Daniela Roncarolo. Their combined expertise contributes to the ongoing research and development of allergy treatments.
Conclusion
Dario Zanoni's contributions to allergy treatment through his innovative patents highlight his role as a leading inventor in this field. His work not only enhances the safety and effectiveness of immunotherapy but also represents a significant advancement in allergy management.